531 results on '"Krug, Utz"'
Search Results
2. Prognostic impact of CEBPA mutational subgroups in adult AML
3. Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)
4. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
5. Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project
6. UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
7. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
8. Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG)
9. Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
10. A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
11. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
12. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
13. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
14. A clinically applicable gene expression–based score predicts resistance to induction treatment in acute myeloid leukemia
15. Friday leukemia—a structural phenomenon
16. Prognostic impact of CEBPA mutational subgroups in adult AML
17. Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)
18. Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
19. The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia
20. Akute myeloische Leukämie beim alten und geriatrischen Patienten
21. P446: COMPREHENSIVE CHARACTERIZATION OF DIFFERENTIAL GENE EXPRESSION AND ISOFORM USAGE IN SPLICING FACTOR-MUTATED ACUTE MYELOID LEUKEMIA USING LONG-READ SEQUENCING
22. P434: MYELODYSPLASIA-RELATED MUTATIONS IN THE NEW ELN CLASSIFICATION: DOES CLONAL SIZE PLAY A ROLE?
23. P457: COMPLEX CARYOTYPE IS AN INDEPENDENT RISK FACTOR IN TP53-MUTATED AML
24. S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
25. Therapy of older persons with acute myeloid leukaemia
26. Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups
27. Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
28. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
29. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
30. Prognostic impact of CEBPAmutational subgroups in adult AML
31. A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
32. German AMLCG-Survivorship Study: Anxiety and Depression Symptoms in AML Long-Term Survivors
33. Secondary Neoplasms in AML Long-Term Survivors: Even More Cancer to Come?
34. Validation of the 2022 European Leukemianet Genetic Risk Stratification of Acute Myeloid Leukemia
35. Life Satisfaction and Quality of Life in AML Long-Term Survivors: Primary Results of the AMLCG-Survivorship Study
36. Sex-Associated Differences in Frequencies and Outcome Prognostication of Recurrent Molecular Features in Adults with Acute Myeloid Leukemia (AML) (AMLCG, CALGB [Alliance])
37. Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome
38. Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML
39. Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML
40. Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines
41. Akute myeloische Leukämie beim alten und geriatrischen Patienten
42. New Molecular Therapy Targets in Acute Myeloid Leukemia
43. Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
44. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
45. Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene
46. Additional file 1 of Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
47. Quality of Life and Life Satisfaction in AML Long-Term Survivors: Primary Results of the AMLCG-Survivorship Study
48. High Prevalence of CHF and Diabetes in AML Long-Term Survivors - a Patient Forever?
49. Multi-Dimensional Analysis of Adult Acute Myeloid Leukemia (AML) Landscape Cross-Continents Reveals Age Associated Trends in Mutations and Outcomes
50. Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome–negative myeloproliferative neoplasms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.